GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tetra Bio Pharma Inc (TSX:TBP) » Definitions » Quick Ratio

Tetra Bio Pharma (TSX:TBP) Quick Ratio : 0.25 (As of Aug. 2022)


View and export this data going back to 2008. Start your Free Trial

What is Tetra Bio Pharma Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Tetra Bio Pharma's quick ratio for the quarter that ended in Aug. 2022 was 0.25.

Tetra Bio Pharma has a quick ratio of 0.25. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Tetra Bio Pharma's Quick Ratio or its related term are showing as below:

TSX:TBP's Quick Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.49
* Ranked among companies with meaningful Quick Ratio only.

Tetra Bio Pharma Quick Ratio Historical Data

The historical data trend for Tetra Bio Pharma's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tetra Bio Pharma Quick Ratio Chart

Tetra Bio Pharma Annual Data
Trend Nov12 Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.91 5.71 1.37 0.53 0.81

Tetra Bio Pharma Quarterly Data
Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.14 0.81 0.88 0.53 0.25

Competitive Comparison of Tetra Bio Pharma's Quick Ratio

For the Biotechnology subindustry, Tetra Bio Pharma's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tetra Bio Pharma's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tetra Bio Pharma's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Tetra Bio Pharma's Quick Ratio falls into.



Tetra Bio Pharma Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Tetra Bio Pharma's Quick Ratio for the fiscal year that ended in Nov. 2021 is calculated as

Quick Ratio (A: Nov. 2021 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(5.95-0)/7.302
=0.81

Tetra Bio Pharma's Quick Ratio for the quarter that ended in Aug. 2022 is calculated as

Quick Ratio (Q: Aug. 2022 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(2.247-0)/8.929
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tetra Bio Pharma  (TSX:TBP) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Tetra Bio Pharma Quick Ratio Related Terms

Thank you for viewing the detailed overview of Tetra Bio Pharma's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tetra Bio Pharma Business Description

Traded in Other Exchanges
N/A
Address
2316 St-Joseph Boulevard, Orleans, ON, CAN, K1C 1E8
Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical programs aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The company with its subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals and Veterinary Products containing cannabinoids. Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.
Executives
Steve Néron Senior Officer
William Cheliak Director
Guy Chamberland Senior Officer
Robert Bechard Senior Officer
Denis Courchesne Director

Tetra Bio Pharma Headlines

No Headlines